Weimin Wang
Founder, Chief Executive Officer at Sanegene Bio
📍 Watertown, Massachusetts, United States
Weimin Wang is the Founder and CEO of Sanegene Bio, a company focused on innovative RNA-based therapeutics. Recognized as a pioneer in oligonucleotide chemistry, his career of over two decades includes key leadership roles at Dicerna Pharmaceuticals, Merck, and Sirna Therapeutics, where he advanced novel RNAi drug development.
There is no publicly available information regarding Weimin Wangs personal life or hobbies.
He is a key inventor of the innovative GalXC™ and GalXC-Plus™ RNAi delivery technologies and is named on over 70 scientific papers and patents.
Read the full overview →Experience
26 Years
Current Role
Founder, Chief Executive Officer
Job Level
Leadership
Location
Watertown, Massachusetts, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Weimin cares about
RNAi Therapeutics
A leader in the field for over 20 years, he has contributed to impactful RNAi medicines and founded Sanegene Bio to focus on this modality.
Drug Delivery Platforms
He was a key inventor of Dicerna's GalXC™ delivery technology and developed one of the first lipid nanoparticle delivery systems at Merck/Sirna.
Career
Work history
2-2021
Founder, Chief Executive Officer
Sanegene Bio
6-2019 - 1-2021
Executive Director
Dicerna Pharmaceuticals, Inc.
1-2014 - 6-2019
Senior Director
Dicerna Pharmaceuticals, Inc.
12-2006 - 12-2013
Research Fellow
Merck
11-1999 - 12-2006
Senior Scientist
Sirna Therapeutics
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
BS
Peking University
Doctor of Philosophy (Ph.D.)
Rutgers University
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.